{"id":"https://openalex.org/W2544346309","doi":"https://doi.org/10.1016/j.jval.2016.09.1000","title":"Cost-Effectiveness of Solifenacin for The Treatment of Overactive Bladder From A Us Private Payer and Medicare Advantage Perspective","display_name":"Cost-Effectiveness of Solifenacin for The Treatment of Overactive Bladder From A Us Private Payer and Medicare Advantage Perspective","publication_year":2016,"publication_date":"2016-11-01","ids":{"openalex":"https://openalex.org/W2544346309","doi":"https://doi.org/10.1016/j.jval.2016.09.1000","mag":"2544346309"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2016.09.1000","doi":"https://doi.org/10.1016/j.jval.2016.09.1000","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.1000","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2016.09.1000","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025645378","display_name":"DB Ng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DB Ng","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., Northbrook, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., Northbrook, IL, USA","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109935587","display_name":"Ronald C. Wielage","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Wielage","raw_affiliation_strings":["Medical Decision Modeling Inc., Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc., Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069837188","display_name":"TM Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"TM Klein","raw_affiliation_strings":["Medical Decision Modeling Inc., Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc., Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109099927","display_name":"RW Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105725","display_name":"Medical Decision Modeling (United States)","ror":"https://ror.org/01h42mb65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RW Klein","raw_affiliation_strings":["Medical Decision Modeling Inc., Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Decision Modeling Inc., Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4210105725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029849735","display_name":"Katherine L. Gooch","orcid":"https://orcid.org/0009-0000-6382-614X","observed_orcids":["https://orcid.org/0009-0000-6382-614X"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Gooch","raw_affiliation_strings":["Astellas Pharma Global Development, Inc., Northbrook, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Inc., Northbrook, IL, USA","institution_ids":["https://openalex.org/I4210165171"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.2338726,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"7","first_page":"A519","last_page":"A519"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9345999956130981,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.04839999973773956,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10418","display_name":"Pelvic floor disorders treatments","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solifenacin","display_name":"solifenacin","score":0.8849999904632568},{"id":"https://openalex.org/keywords/fesoterodine","display_name":"fesoterodine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8349999785423279},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.8870000243186951},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.8349999785423279},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8880000114440918},{"id":"https://openalex.org/keywords/incontinence","display_name":"incontinence","score":0.6439999938011169},{"id":"https://openalex.org/keywords/micturition-frequency","display_name":"micturition frequency","score":0.9800000190734863},{"id":"https://openalex.org/keywords/network-meta-analysis","display_name":"network meta-analysis","score":0.7379999756813049},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/willingness-to-pay-threshold","display_name":"willingness-to-pay threshold","score":0.7319999933242798},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.5960000157356262},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2779502394","wikidata":"https://www.wikidata.org/wiki/Q59575279","display_name":"Solifenacin","level":4,"score":0.9458977580070496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8568470478057861},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.8453326225280762},{"id":"https://openalex.org/C2778531004","wikidata":"https://www.wikidata.org/wiki/Q281490","display_name":"Urinary incontinence","level":2,"score":0.6488010883331299},{"id":"https://openalex.org/C175768497","wikidata":"https://www.wikidata.org/wiki/Q105726","display_name":"Urination","level":3,"score":0.6136119365692139},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5502455830574036},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5155084133148193},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5074719786643982},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4755254089832306},{"id":"https://openalex.org/C2781020410","wikidata":"https://www.wikidata.org/wiki/Q424312","display_name":"Tolterodine","level":4,"score":0.43522369861602783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3583572208881378},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.20375844836235046},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2016.09.1000","doi":"https://doi.org/10.1016/j.jval.2016.09.1000","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.1000","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2016.09.1000","doi":"https://doi.org/10.1016/j.jval.2016.09.1000","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2016.09.1000","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2072244742","https://openalex.org/W2109858998","https://openalex.org/W4249422538","https://openalex.org/W2037750235","https://openalex.org/W1587585344","https://openalex.org/W2399603275","https://openalex.org/W2043977360","https://openalex.org/W2962813502","https://openalex.org/W2028475108","https://openalex.org/W2395205213"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-11-04T00:00:00"}